Regenxbio Inc (RGNX)
7.63
+0.22
(+2.97%)
USD |
NASDAQ |
Dec 20, 16:00
7.71
+0.08
(+1.05%)
After-Hours: 20:00
Regenxbio Total Assets (Quarterly): 519.11M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 772.01M |
| Vertex Pharmaceuticals Inc | 22.24B |
| Sarepta Therapeutics Inc | 3.600B |
| Edgewise Therapeutics Inc | 511.28M |
| Entrada Therapeutics Inc | 554.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 217.70M |
| Shareholders Equity (Quarterly) | 301.42M |
| Current Ratio | 3.051 |